IMAC Holdings, Inc.

IMAC Holdings, Inc.

IMAC Holdings, Inc. was incorporated in Delaware in 2015 and went public via a reverse merger in 2017, trading on the OTC Markets under the symbol IMAC. The company's wealth origin is tied to its public listing and subsequent capital raises. The company's strategy involves acquiring and operating outpatient medical clinics that specialize in regenerative medicine therapies, such as stem cell and platelet-rich plasma treatments, alongside physical rehabilitation. As of its most recent public filings, IMAC owned and operated a small number of clinics in the United States. The firm's asset-class mix is primarily health care operations, with no disclosed investment in funds or financial securities. The firm's scale is modest, with revenue in the low millions and a slim workforce, as reported in its public filings. No additional offices beyond its headquarters in Boca Raton, Florida, have been confirmed. The company has not disclosed any adjacent philanthropic vehicles or external investment arms. IMAC Holdings's structural differentiator lies in its public company structure rather than a private family office or investment firm. It raises capital through equity markets and operates clinical facilities directly, a model uncommon among traditional family offices. The firm's public status subjects it to SEC reporting, offering a level of transparency not typical for private entities.